CIK: 1762611 - Address: C/O Regulus Therapeutics Inc., 4224 Campus Point Court #210, San Diego, CA 92121
15 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/15/25 17:00
1/13/25
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS.m-551.260-44-4750D
1/18/24 20:23
1/18/24
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-71.190-5-3510D
5/17/21 19:12
5/17/21
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-10.89000-1-242D
2/17/21 17:23
2/16/21
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-11.720-1-243D
11/18/20 16:10
11/16/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS00.52110-1-326D
8/17/20 20:21
8/14/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-10.60500-1-327D
5/18/20 16:27
5/15/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-10.62680-1-328D
2/19/20 18:08
2/18/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-10.83050-1-328D
1/3/20 16:06
1/2/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-20.96670-2-729D
11/15/19 17:37
11/14/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-10.64000-1-332D
10/2/19 18:50
10/1/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-20.68270-2-732D
8/16/19 16:16
8/15/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS00.55060-1-335D
7/2/19 17:42
7/1/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-31.310-2-636D
5/16/19 17:21
5/15/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS.d-101.410-7-1059D
4/3/19 16:15
4/1/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAker Christopher RayCAOSVP,GCS-30.98120-3-306D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact